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AbstrAct
Background Time to treatment in many conditions, 
particularly acute coronary syndrome, is critical to 
reducing mortality. Delay between onset of symptoms 
and treatment remains a worldwide problem. Reducing 
patient delay has been particularly challenging. 
Embedding behaviour change techniques (BCTs) within 
interventions might lead to shorter delay.
Objective To identify which BCTs are associated 
with reductions in patient delay among people with 
symptoms or conditions where time to treatment is 
critical.
Methods The data sources were Cochrane Library, 
MEDLINE, EMBASE, Cumulative Index to Nursing and 
Allied Health Literature, and PsycINFO. Study eligibility 
criteria include intervention evaluations (randomised 
controlled trials, controlled clinical trials and cohort 
studies) involving adults (aged >18 years) and including 
an outcome measure of patient delay up to August 
2016. Study appraisal and synthesis methods include 
screening potential studies using a transparent, 
replicable process. Study characteristics, outcomes and 
BCTs were extracted from eligible studies.
Results From 39 studies (200 538 participants), 
just over half (n=20) reported a significant reduction 
in delay. 19 BCTs were identified, plus 5 additional 
techniques, with a mean of 2 (SD=2.3) BCTs and 2 
(SD=0.7) per intervention. No clear pattern between 
BCTs and effectiveness was found. In studies examining 
patient delay specifically, three of four studies that 
included two or more BCTs, in addition to the two 
most commonly used additional techniques, reported a 
significant reduction in delay.
Conclusions Around half of the interventions to reduce 
prehospital delay with time-critical symptoms report a 
significant reduction in delay time. It is not clear what 
differentiates effective from non-effective interventions, 
although in relation to patient delay particularly 
additional use of BCTs might be helpful.
Trial registration number CRD42014013106.
InTROduCTIOn
It has long been recognised that time to 
treatment in acute coronary syndrome 
(ACS) is critical to reducing mortality.1 
Contemporary healthcare systems and path-
ways are designed to facilitate immediate 
Key questions
What is already known about this subject?
 ► Patient delay with symptoms of time-critical condi-
tions like acute coronary syndrome (ACS) remains a 
worldwide problem.
 ► Interventions to reduce delay have had mixed 
results.
 ► Embedding behaviour change techniques (BCTs) 
within interventions might be important in relation 
to effectiveness.
What does this study add?
 ► This systematic review has found that only half of 
the interventions to reduce prehospital delay with 
time-critical symptoms report significantly reduced 
delay times.
 ► It is unclear what differentiates effective from 
non-effective interventions.
 ► However, some limited evidence suggests that ad-
ditional use of BCTs might be helpful in reducing 
patient delay in particular.
How might this impact on clinical practice?
 ► Our results suggest that the development of in-
terventions that incorporate more BCTs might be 
a promising next step in addressing the important 
and long-standing problem of patient delay with 
time-critical symptoms.
 ► If interventions could be developed that successfully 
reduce patient delay, they have the potential to sig-
nificantly reduce mortality and morbidity from ACS 
and other time-critical conditions.
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Figure 1 Search strategy.
assessment and care where ACS is suspected.2 This 
often includes an emergency telephone service, rapid 
response by paramedic, transfer to hospital by ambu-
lance, immediate triage, and prompt initiation of 
reperfusion treatments such as percutaneous coro-
nary intervention or thrombolysis.3 4 Much has been 
achieved and continues to be achieved by improving 
emergency care services. Mortality from cardiovascular 
disease has declined dramatically in the last 30 years in 
the UK5 and other high-income countries,6 with 8% of 
the reduction attributed to initial treatment of acute 
myocardial infarction.7 European registry data show 
continuing improvements in hospital reperfusion times 
as well as reduced mortality for people with ACS.8
Despite the achievements in emergency care, delays 
between onset of symptoms and receipt of treatment 
persist.9 Recently, an Irish study10 reported median 
delay times of more than 7 hours in their control 
group. The largest interval in pretreatment time has 
been identified as ‘patient decision time’.11 Patient deci-
sion time (often referred to as ‘patient delay’) refers 
to the interval between onset of symptoms and seeking 
medical help and has proved much more challenging 
to reduce than other components of delay, such as 
transportation and hospital delays, also referred to as 
utilisation delay.12 However, if reductions in patient 
delay could be achieved, they offer the potential to lead 
to significant reductions in mortality for ACS.13
A number of interventions aimed at reducing patient 
delay times for ACS have been trialled, but to date the 
pattern of results is mixed. A systematic review which 
focused on mass media interventions to reduce delay 
concluded that they had little success in changing 
behaviour.14 More recently, an alternative strategy of 
intensive, targeted interventions for people at high risk 
of ACS (those with existing coronary heart disease) 
has been trialled in the USA15 and Ireland.10 The two 
interventions were strikingly similar, both described 
as comprising an individualised, one-on-one session of 
approximately 30–40 min with the patient and signif-
icant other, with a 15 min follow-up phone call. Both 
studies cite Leventhal’s theory of self-regulation as the 
underlying theoretical framework and provide informa-
tion about symptoms, instructions of how and when to 
call for help, anticipate and plan for possible emotional 
responses, involve significant others, encourage signif-
icant others to deputise in the event of symptoms, and 
provide written instructions for participants to take 
away. However while Mooney et al10 found a significant 
difference postintervention between the intervention 
and the control group, Dracup et al15 did not. Given that 
two very similar interventions produced very different 
results, it is yet to be determined what the effective 
components of an intervention to reduce patient delay 
are.
There is evidence to suggest that embedding 
evidence-based behaviour change techniques (BCTs) 
(eg, goal-setting, action planning)16 within interven-
tions is more likely to lead to successful behaviour 
change. For example, an intervention using established 
BCTs has been effective in reducing patients’ intended 
delay time with symptoms of lung cancer, another 
time-sensitive condition.17 18 The publication of the 
Behaviour Change Techniques Taxonomy V.1 (BCTT 
V.1)19 provides an opportunity to systematically examine 
previous interventions to establish which specific BCTs 
are associated with effective interventions, but to date 
this has not been undertaken in the context of inter-
ventions to reduce patient delay with symptoms of 
ACS. Patient delay is critical for a range of time-critical 
conditions, including but not limited to ACS.20 Given 
that patient perceptions of symptoms guide patient 
delay, rather than clinician subsequent diagnoses, we 
examined interventions that target patient recognition 
and response to acute conditions to maximise learning 
from the available literature.
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Table1 Skewness of patient delay time data in studies that 
reported means and SD
Study Mean SD SD ×2
Likely 
skewness
Before and after studies
  Addo et al66 B 374 512 1024 Skewed
  A 296.8 356.3 712.6
  Diercks et 
al56
B 232 271.3 542.6 Skewed
  A 224 257.9 515.8
  Naegeli et 
al63
B 247 248.4 496.8 Skewed
  A 223.3 229.8 459.6
  Wolters et 
al51
B 810 4176 8352 Skewed
  A 318 1146 2292
Controlled studies
  Dracup et 
al15
I 257.4 20.40 40.8 Not skewed
  C 304.8 41.4 82.8
  Luepker et 
al31
I 130.2 8.25 16.5 Not skewed
  C 304.8 41.40 82.8
  Sun et al37 I 498 348 696 Skewed
  C 630 390 780
B-before A-after i-Intervention c- control
Therefore this paper reports the results of a system-
atic review which for the first time aimed to identify 
which BCTs are associated with effective interventions 
to reduce patient delay (or prompt rapid help-seeking) 
among people with symptoms or conditions where time 
to treatment is critical.
MeTHOds
Protocol and registration
In line with best practice,21 a review protocol was 
published in 201420 and registered with the PROS-
PERO International prospective register of systematic 
reviews based at the University of York and can be 
accessed through the following website: http://www. 
crd. york. ac. uk/ PROSPERO/ display_ record. asp? ID= 
CRD42014013106.
eligibility criteria
Studies were included if they met the following inclusion 
criteria:
Types of study
Any intervention study (including randomised 
controlled trials [RCTs], controlled clinical trials and 
cohort studies) which includes an outcome measure of 
patient delay/time to presentation with symptoms (ie, 
behaviour).
Types of participants
Adults (>18 years) with symptoms or conditions where 
time to treatment is critical (ie, timing of presentation 
has a demonstrated effect on mortality).
Types of interventions
Any intervention where the stated aim was to reduce 
patient delay/time to presentation to health services 
(eg, patient education intervention or multimedia 
public health campaign).
Types of outcome measure
To be included, studies had to include a measure of 
patient delay time (ie, interval between the onset 
of symptoms and seeking medical help), which is 
the primary outcome of interest in this review. The 
following secondary outcomes were also examined: 
intentions to seek help without delay, number and type 
of presentations with symptoms (general practitioner 
[GP], hospital, ambulance), and number of deaths and 
adverse events.
Papers were excluded if they did not report a primary 
empirical study of an intervention (ie, reviews, edito-
rials, opinion pieces, commentaries, letters to editors, 
papers describing intervention), did not include a 
measure of prehospital delay and only included partici-
pants <18 years. Studies were not excluded on the basis 
of language or year of publication.
Information sources and search strategy
A comprehensive search strategy was developed to 
identify primary studies evaluating interventions aimed 
at reducing patient delay. Five electronic databases—
Cochrane Library, MEDLINE, EMBASE, Cumulative 
Index to Nursing and Allied Health Literature, and 
PsycINFO and the National Research Register (NRR)—
were searched independently for publications from 
inception of each database to 1 August 2016. The search 
strategy combined terms related to time-critical condi-
tions and patient delay with the AND operator. A third 
term related to intervention was combined by AND with 
the above terms to narrow down the search and limit 
it to studies reporting on an intervention. Both index 
terms (ie, medical subject headings/subject headings/
thesaurus) and free-text keywords were used. The full 
search strategy is presented in figure 1. The database 
searches were supplemented with searches through the 
following other sources: (1) reference lists of all included 
studies and previous reviews of similar interventions, (2) 
citations of included studies using three citation index 
databases (Science Citation Index, Social Sciences Cita-
tion Index and Arts, and Humanities Citation Index), 
(3) National Research Register, and (4) email contact 
with authors of conference abstracts and of studies iden-
tified through the National Research Register to obtain 
details of ongoing, unpublished or recently completed 
research.
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Figure 2 Flow chart of studies screened, excluded and included in review.
study selection
Initial screening of titles was undertaken by one reviewer 
(PA) to exclude any that were obviously irrelevant. The 
reliability of this screening was assessed by a second 
reviewer (BF) independently screening a subset of the 
titles. The abstracts of studies included from their titles 
were then screened independently by two reviewers (PA 
and BF) applying the inclusion/exclusion criteria. Full 
texts of the studies that were considered potentially rele-
vant by either reviewer were screened independently by 
the same reviewers. At the full-text screening stage, any 
disagreements between the reviewers over inclusion or 
exclusion were resolved by seeking independent opinion 
from a third reviewer (SUD). A similar process was 
applied to the screening of records identified from cita-
tion tracking. Studies identified from the reference lists 
of included studies, previous reviews of similar interven-
tions, author contact and the National Research Register 
were screened first by abstract and then by full text inde-
pendently by the two reviewers (PA and BF).
Assessment of methodological quality and risk of bias
Methodological quality of the included studies was 
assessed using the EPHPP Quality Assessment Tool for 
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Figure 3 Update literature search.
Quantitative Studies developed by the Effective Public 
Health Practice Project (EPHPP), Canada.22 This tool 
was chosen as it enables assessment of multiple quanti-
tative study designs on a comprehensive set of criteria 
and is recommended by the Cochrane Handbook for use 
in reviews of public health and health promotion inter-
ventions that use a variety of study designs.23 It enables a 
rating of strong, moderate or weak on six methodological 
dimensions that assess the risk of bias: selection bias, allo-
cation bias, control of confounders, blinding of outcome 
assessors, data collection methods, and withdrawals and 
dropouts. Ratings on these dimensions feed into a global 
rating. The tool provides two additional questions, not 
involved in the global rating, one assesses intervention 
integrity and the other appropriateness of analysis. 
The tool has been demonstrated to have content and 
construct validity and test–retest reliability.24 Using this 
tool, the included studies were independently assessed by 
two reviewers (PA and SUD) for methodological quality, 
with discrepancies being resolved through discussion.
data extraction
Data extraction was performed by one team member 
(PA) on all studies in English and a German-speaking 
team member (SUD) on the studies in German. Studies 
in Norwegian and Swedish were translated by a native 
Norwegian-Swedish speaker. Guided by the Consolidated 
Standards of Reporting Trials25 and the Template for 
Intervention Description and Replication26 guidelines, a 
data extraction form was developed in MS Excel, piloted 
on six studies by two reviewers (PA and SUD) and revised 
to ensure that all essential information was recorded 
systematically. The form recorded the following informa-
tion for each included study: study details (author and 
date, location, study duration, study age, clinical condi-
tion, objectives), study methods (design, number of study 
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Table 2 Methodological quality ratings for included studies (n=39)
Author and year
Selection 
bias Design Confounders Blinding
Data 
collection
methods
Withdrawals
and dropouts
EPHPP 
global
rating Total score
RCTs (n=7) Of 18
Blank and Smithkline30 2002 1 1 3 3 1 3 3 12
Boden-Albala et al,34 2015 2 1 1 2 1 1 1 8
Dracup et al,15 2009 1 1 1 1 3 1 2 8
Luepker et al,31 2000 2 1 1 1 1 3 2 9
Meischke et al,32 1997 3 1 3 1 3 NA 3 11/15
Mooney et al,10 2014 2 1 1 1 1 1 1 7
Müller-Nordhorn et al,33 2009 1 1 1 1 3 1 2 8
Controlled before and after studies (n=3) Of 12
Morgenstern et al,35 2002 1 2 3 2 1 NA NA 6
Rowley et al,36 1982 3 2 NA 2 3 NA NA 10
Xin-gang et al,37 2013 2 2 3 2 3 NA NA 9
Uncontrolled before and after studies /ITS (n=26) Of 12
Addo et al,66 2012 2 2 NA 2 3 NA NA 9
Alberts et al,59 1992 2 2 NA 2 3 NA NA 9
Barsan et al,60 1994 2 2 NA 2 3 NA NA 9
Bett et al,45 2004 2 2 NA 2 3 NA NA 9
Bett et al,46 1993 2 2 NA 3 3 NA NA 10
Black and Brown,62 1973 2 2 NA 2 3 3 NA 9
Breuer et al,54 1999 1 2 NA 2 3 NA NA 8
Camerlingo et al,64 2014 2 2 NA 2 3 NA NA 9
Diercks et al,56 2010 2 2 NA 3 3 NA NA 10
Gaspoz et al,48 1996 2 2 NA 3 3 NA NA 10
Herlitz et al,55 1992 2 2 NA 2 3 NA NA 9
Ho et al,1 1989 3 2 NA 2 3 3 NA 10
Hodgson et al,38 2007 1 2 NA 2 3 NA NA 8
Luiz et al,49 2001 1 2 NA 2 3 NA NA 8
Maeso-Madronero et al,52 2000 1 2 NA 3 3 NA NA 9
Mellon et al,40 2014 2 2 NA 2 3 NA NA 9
Mitic and Perkins,57 1984 2 2 NA 2 3 NA NA 9
Moses et al,67 1991 2 2 NA 2 3 NA NA 9
Naegeli et al,63 2011 2 2 NA 2 3 NA NA 9
Nishijima et al,65 2016 2 2 NA 2 3 NA NA 9
Rau et al,53 2008 1 2 NA 2 3 NA NA 8
Rustige et al,41 1992 2 2 NA 2 3 NA NA 9
Thomassen et al,50 1999 3 2 NA 2 3 NA NA 10
Waters et al,47 1983 1 2 NA 2 3 NA NA 8
Wolters et al,51 2015 2 2 NA 2 3 NA NA 9
Wright et al,58 2001 1 2 NA 2 3 NA NA 8
Post-test only (n=2) Of 12
Bray et al,44 2015 2 3 NA 2 3 NA NA 10
Månsson et al,43 1999 2 3 NA 3 3 NA NA 11
Case–control study (n=1) Of 12
Tummala and Farshid,42 2015 2 2 NA 2 3 NA NA 9
As the global rating, following EPHPP guidelines, could not be calculated for studies with non-randomised designs, we also calculated a sum total of the ratings 
across all dimensions that were applicable to the study design. This total score ranges from 6 to 18 if all six dimensions are applicable and from 4 to 12 if only four 
dimensions are applicable. Lower scores suggest better overall methodological quality and higher scores suggest poorer quality.
EPHPP, Effective Public Health Practice Project; ITS, interrupted time series; NA, not applicable; RCTs, randomised controlled trials.
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Table 3 Intervention integrity and consistency ratings for included studies (n=39)
Author and year Integrity Consistency Contamination Unit of allocation Unit of analysis
Intention To 
Treat (ITT)
RCTs
Blank and Smithkline 1 3 6 Individual Individual 2
Boden-Albala et al,34 2015 1 3 6 Individual Individual 1
Dracup et al,15 2009 4 3 6 Individual Individual 2
Luepker et al,31 2000 4 3 6 Community Both NA
Meischke et al,32 1997 4 2 6 Individual Individual 3
Mooney et al,10 2014 4 1 6 Individual Individual 1
Müller-Nordhorn et al,33 2009 4 3 6 Community Community NA
Controlled before and after studies
Morgenstern et al,35 2002 4 3 6 Community Individual 1
Rowley et al,36 1982 4 3 6 Practice Practice 3
Xin-gang et al,37 2013 4 3 6 Community Individual 3
Uncontrolled before and after studies/ITS
Addo et al,66 2012 4 3 6 Community Individual NA
Alberts et al,59 1992 4 3 6 Individual Individual NA
Barsan et al,60 1994 4 3 6 Community Individual NA
Bett et al,45 2005 4 3 6 Community Individual NA
Bett et al,46 1993 3 3 6 Community Individual NA
Black and Brown,62 1973 4 3 6 Community Individual NA
Breuer et al,54 1999 4 3 6 Community Individual NA
Camerlingo et al,64 2014 4 2 6 Community Individual NA
Diercks et al,56 2010 4 3 6 Community Individual NA
Gaspoz et al,48 1996 4 3 6 Community Individual NA
Herlitz et al,55 1992 2 3 6 Community Individual NA
Ho et al,1 1989 4 3 6 Community Individual NA
Hodgson et al,38 2007 4 3 6 Community Individual NA
Luiz et al,49 2001 4 3 6 Community Individual NA
Maeso-Madronero et al,52 2000 4 3 6 Community Individual 1
Mellon et al,40 2014 4 2 6 Community Individual NA
Mitic and Perkins,57 1984 4 3 6 Community Individual NA
Moses et al,67 1991 4 3 6 Community Individual NA
Naegeli et al,63 2011 4 3 6 Community Individual NA
Nishijima et al,65 2016 4 2 6 Community Individual NA
Rau et al,53 2005 4 3 6 Community Individual 1
Rustige et al,41 1992 4 3 6 Community Individual NA
Thomassen et al,50 1999 4 3 6 Community Individual NA
Waters et al,47 1983 4 3 6 Community Individual NA
Wolters et al,51 2015 4 3 6 Community Individual NA
Wright et al,58 2001 4 3 6 Community Individual NA
Post-test only studies (n=2)
Bray et al,44 2015 2 2 6 Community Individual NA
Månsson et al,43 1999 4 3 6 Community Individual NA
Case–control study (n=1)
Tummala and Farshid,42 2015 2 2 6 Community Individual NA
ITS, interrupted time series; ITT, intention to treat; NA, not available.
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Table 4 Summary table of study and intervention characteristics associated with effectiveness of interventions aimed at 
reducing patient delay
Study details Total (N)
Significant 
reduction in patient 
delay
No significant 
reduction in patient 
delay
Study design 
  RCTs/Cluster RCT 7 2 5
  Controlled before and after 3 2 1
  Uncontrolled before and after/ITS 26 15 11
  Post-test only 2 1 1
  Case–control study 1 0 0
Theoretical underpinning 
  Yes 8 2 6
  No 31 18 13
Intervention mode of delivery 
  Population-level, mass media 30 17 13
  Individual-level, face-to-face 4 1 3
  Individual-level, direct mailing 3 2 1
  Both, mass media + direct mailing 2 0 2
Intervention intensity 
  Campaigns ≤12 months 15 8 7
  Campaigns >12 months 8 4 4
Population 
  Confirmed diagnosis 15 8 7
  Suspected diagnosis 24 12 12
Year of publication 
  In/before 2000 18 10 8
  After 2000 21 10 11
Measurement of delay 
  Symptom onset to hospital arrival 24 12 12
  Symptom onset to first seeking help 5 1 4
  Both 5 4 1
  Not reported 5 3 2
Clinical context 
  ACS 5 3 2
  MI 16 8 8
  Stroke 15 9 6
  Breast cancer 2 0 2
  Chest pain 1 0 1
Overall study quality based on total score
  Randomised studies (total quality score range 6–18; good–poor quality)
  Scored 6–9 5 2 3
  Scored 10–14 2 0 2
  Scored 15–18 0 0 0
  Non-randomised studies (total quality score range 4–12; good–poor quality)
  Scored 4–5 1 0 1
  Scored 6–8 20 13 7
  Scored 9–12 11 5 6
ACS, acute coronary syndrome; ITS, interrupted time series; MI, myocardial infarction; RCTs, randomised controlled trials.
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Table 5 Distribution of BCTs among studies of effective and ineffective interventions (n=39)
BCT 
number BCT label Frequency
Effective studies 
in which this BCT 
is present, n (out 
of 20)
Ineffective 
studies in which 
this BCT is 
present, n (out 
of 19)
1.1 Goal-setting (behaviour) 1 1 0
1.2 Problem-solving 6 3 3
1.4 Action planning 27 14 13
3.1 Social support (unspecified) 2 1 1
3.2 Social support (practical) 3 1 2
4.1 Instruction on how to perform the behaviour 4 1 3
4.2 Information about antecedents 1 0 1
5.1 Information about health consequences 16 8 8
5.2 Salience of consequences 4 1 3
6.1 Demonstration of the behaviour 3 0 3
7.1 Prompts and cues 5 3 2
8.1 Behavioural practice/rehearsal 3 1 2
8.2 Behaviour substitution 1 1 0
9.1 Credible source 5 3 2
11.2 Reduce negative emotions 1 0 1
12.5 Adding objects to the environment 3 2 1
13.1 Identification of self as a role model 1 0 1
13.2 Framing/Reframing 1 1 0
15.1 Verbal persuasion about capability 1 0 1
Additional techniques 
AT1 Provision of factual information (eg, on signs and symptoms) 36 18 18
AT2 Instruction on behaviour (what to do) 32 17 15
AT3 Instruction on intermediate behaviour 1 0 1
AT4 Information about health consequences of intermediate 
behaviour
1 0 1
AT5 Reflecting on past experiences 1 1 0
BCTs, behaviour change techniques.
arms, setting, target population, sample size estimation, 
sample size actual, sampling and recruitment method, 
outcomes, outcome definition, analysis, dates of recruit-
ment), details of intervention and comparison (name, 
theory, materials, provider, setting, delivery format, 
intensity, tailoring, modifications, planned and actual 
fidelity assessment), BCTs included in the intervention 
and comparison conditions, and study results (partici-
pant flow, participant characteristics, results for primary 
and secondary outcomes, ancillary analysis, adverse 
outcomes, authors’ conclusion). To assess the feasibility 
of meta-analysis, data on mean delay time and SDs (for 
differences in delay times between before and after, or 
intervention and control) were extracted where avail-
able. A third member of the team (BF) independently 
performed data extraction on a 20% subset of the 
included studies (n=5) to assess reliability. No discrepan-
cies in independently extracted data were found.
Identification of BCTs
To identify the BCTs, descriptions of the interventions 
were coded using the 93-item BCTT V.1.19 The coding 
was undertaken independently by two health psycholo-
gists (PA and SUD). First, the coding of BCTs was piloted 
on six intervention descriptions, and any discrepancies 
were discussed and resolved by realigning interpreta-
tions. During this pilot, it became apparent that inter-
ventions included techniques that were not listed in 
BCTT V.1—these were captured as ‘additional techniques’. 
The two BCT coders agreed on their working labels and 
definitions for additional techniques prior to coding the 
remaining studies (see online supplementary appendix 
1). Second, BCTT V.1 along with the additional tech-
niques was applied to intervention descriptions of all 
remaining studies (n=34). Of these, 28 studies available 
in English were dual-coded by two independent reviewers 
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Figure 4 BCTs and effectiveness.
Figure 5 Additional techniques and effectiveness.
and six studies in German were single-coded by one 
reviewer (SUD).
From the first 22 dual-coded studies, a total of 58 
discrepancies were observed from 2090 instances of 
coding. The average kappa and prevalence-adjusted 
and bias-adjusted kappa (PABAK) scores, calculated for 
the BCTs identified as present in at least four studies by 
either reviewer, reflected poor agreement (kappa=0.49, 
PABAK=0.58). As the level of agreement was poor, the 
discrepancies were examined to determine if they were 
random or systematic, that is, one reviewer consistently 
overcoding/undercoding a specific BCT compared with 
the other. The systematic discrepancies were discussed 
in terms of differences in interpretations of BCTs (for 
action planning, information about health conse-
quences, credible source and problem-solving) and 
resolved through consensus (see online supplementary 
file appendix 1). With agreed interpretation of defini-
tions in mind, both reviewers recoded the interventions 
independently. Following recoding, a total of 33 discrep-
ancies were observed, but the average kappa and PABAK 
scores improved to reflect satisfactory levels of agreement 
(kappa=0.58, PABAK=0.77). The remaining discrepan-
cies were resolved through discussion with a third inde-
pendent reviewer expert in identification of BCTs (MJ).
Methodological quality
During methodological quality assessment using the 
EPHPP tool,22 it became apparent that some items 
of the tool were not applicable to the design of some 
of the studies and hence were not rated. For uncon-
trolled before and after studies (n=24), the question on 
‘confounders’—assessing whether there are important 
differences between two groups prior to intervention—
was not applicable due to a lack of a comparison group. 
Similarly, the questions on ‘withdrawals and drop-outs’ 
and ‘intention to treat analysis’ were not applicable as 
the before and after assessments of patient delay were 
carried out in different groups of people. For controlled 
before and after studies of public health interventions 
targeted at the whole community (n=3), the question 
on ‘withdrawals and drop-outs’ was not applicable as the 
people not remaining in the study at final data collec-
tion period were not intentional withdrawals or dropouts 
but those who did not have an ‘event’ requiring urgent 
medical help. The EPHPP global ratings were therefore 
only derived for studies with RCT designs.
synthesis and analysis
The primary outcome of interest was patient decision time 
(patient delay). The original review protocol proposed 
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Table 6 Summary table of overall methodological quality ratings associated with intervention effectiveness
Author and year EPHPP global rating Total score
Did intervention reduce 
patient delay significantly?
RCTs (n=7)
  Blank and Smithkline 3 12/18 No
  Boden-Albala et al,34 2015 1 8/18 No
  Dracup et al,15 2009 2 8/18 No
  Luepker et al,31 2000 2 9/18 No
  Meischke et al,32 1997 3 11/15 No
  Mooney et al,10 2014 1 7/18 Yes
  Müller-Nordhorn et al,33 2009 2 8/18 Yes
Controlled before and after studies (n=3)
  Morgenstern et al,35 2002 NA 6/12 No
  Rowley et al,36 1982 NA 10/12 Yes
  Xin-gang et al,37 2013 NA 9/12 Yes
Uncontrolled before and after studies /ITS (n=26)
  Addo et al,66 2012 NA 9/12 No
  Alberts et al,59 1992 NA 9/12 Yes
  Barsan et al,60 1994 NA 9/12 Yes
  Bett et al,45 2005 NA 9/12 No
  Bett et al,46 1993 NA 10/12 No
  Black and Brown,62 1973 NA 9/12 Yes
  Breuer et al,54 1999 NA 8/12 Yes
  Camerlingo et al,64 2014 NA 9/12 Yes
  Diercks et al,56 2010 NA 10/12 No
  Gaspoz et al,48 1996 NA 10/12 Yes
  Herlitz et al,55 1992 NA 9/12 Yes
  Ho et al,1 1989 NA 10/12 No
  Hodgson et al,38 2007 NA 8/12 Yes
  Luiz et al,49 2001 NA 8/12 Yes
  Maeso-Madronero et al,52 2000 NA 9/12 Yes
  Mellon et al,40 2014 NA 9/12 No
  Mitic and Perkins,57 1984 NA 9/12 Yes
  Moses et al,67 1991 NA 9/12 No
  Naegeli et al,63 2011 NA 9/12 Yes
  Nishijima et al,65 2016 NA 9/12 Yes
  Rau et al,53 2008 NA 8/12 No
  Rustige et al,41 1992 NA 9/12 Yes
  Thomassen et al,50 1999 NA 10/12 No
  Waters et al,47 1983 NA 8/12 No
  Wolters et al,51 2015 NA 9/12 Yes
  Wright et al,58 2001 NA 8/12 No
Post-test only (n=2)
  Bray et al,44 2015 NA 10/12 Yes
  Månsson et al,43 1999 NA 11/12 No
Case–control study (n=1)
  Tummala and Farshid,42 2015 NA 9/12 No
EPHPP, Effective Public Health Practice Project; ITS, interrupted time series; NA, not available; RCTs, randomised controlled trials.
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Table 7 BCTs and additional techniques used in effective and ineffective studies measuring patient delay (n=10)
BCT 
number BCT label Frequency
Effective studies in 
which this BCT is 
present, n (n=5)
Ineffective 
studies in which 
this BCT is 
present, n (n=5)
1.1 Goal-setting (behaviour) 0 0 0
1.2 Problem-solving 1 1 0
1.4 Action planning 6 3 3
3.1 Social support (unspecified) 0 0 0
3.2 Social support (practical) 0 0 0
4.1 Instruction on how to perform the behaviour 1 1 0
4.2 Information about antecedents 0 0 0
5.1 Information about health consequences 4 2 2
5.2 Salience of consequences 2 1 1
6.1 Demonstration of the behaviour 0 0 0
7.1 Prompts and cues 1 1 0
8.1 Behavioural practice/rehearsal 0 0 0
8.2 Behaviour substitution 0 0 0
9.1 Credible source 2 2 0
11.2 Reduce negative emotions 0 0 0
12.5 Adding objects to the environment 1 1 0
13.1 Identification of self as a role model 0 0 0
13.2 Framing/Reframing 0 0 0
15.1 Verbal persuasion about capability 0 0 0
Additional techniques 
AT1 Provision of factual information (eg, on signs and symptoms of disease) 10 5 5
AT2 Instruction on behaviour (what to do) 9 5 4
AT3 Instruction on intermediate behaviour 0 0 0
AT4 Information about health consequences of intermediate behaviour 0 0 0
AT5 Reflecting on past experiences 0 0 0
BCTs, behaviour change techniques.
that studies would be analysed narratively, and meta-anal-
yses with subgroup analyses would be conducted where 
the data were appropriate for such analysis. However the 
data were not suitable for such meta-analyses as informa-
tion on means and SDs was missing, data were skewed, 
and there was significant heterogeneity across studies 
in terms of study design, intervention target, mode of 
delivery, target population and assessment of patient 
delay.
Means with or without SDs were reported in 13 studies. 
Fifteen of 27 authors of the remaining studies were 
contacted to request means and SD data. Ten of 15 
authors contacted to request these data replied; data were 
no longer available for 8 studies. Two studies required 
additional analysis to obtain means and SDs as the data 
were not normally distributed or the sample sizes were 
small. For the remainder of studies (n=5), means were 
derived from the medians, sample size, and first and third 
quartiles, if reported, using a formula by Wan et al.27 This 
resulted in 18 studies for which means were available, 10 
of which also reported SDs (see table 1).
In seven studies for which both means and SDs were 
available, either reported or derived, skewness was esti-
mated using the criterion suggested by Altman and 
Bland,28 that is, data are likely to be skewed if the mean 
is smaller than twice the SD. As shown in table 1, patient 
delay time data were likely to be skewed in seven of the 
ten studies, and we were therefore unable to combine 
studies into a meta-analysis. Instead, the results are 
synthesised and presented narratively following guidance 
on conducting systematic reviews of health promotion 
and public health interventions.23 29
As the main aim of this review was to identify what 
is effective in reducing patient delay, it was particu-
larly important to examine the studies which measured 
patient delay distinct from those which measured prehos-
pital time. Studies which measure prehospital time have 
the potential to both overestimate and underestimate 
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the ability of interventions to reduce patient delay. For 
example, reductions in other elements of prehospital 
time such as transportation time might be erroneously 
attributed to the patient delay intervention (leading to 
overestimation of its effect), or similarly increases in 
transportation time could ‘cancel out’ the benefits of an 
effective patient delay intervention (underestimation).
ResulTs
Original database searches (see figure 2) identified 20 
996 citations, with 18 285 remaining after removing the 
duplicates. Searches through other sources (citation 
tracking, reference lists, National Research Register, 
contact with authors in the field) identified 824 addi-
tional citations. A total of 19 109 titles were screened. The 
initial screening of titles identified from database search 
and citation tracking was undertaken by one reviewer 
(PA), and the reliability of this screening was assessed by 
a second reviewer (BF) independently screening a subset 
of the titles.
Titles identified from database search
Just under 5% (n=909) of the number of titles identified 
from the database search were double-screened. The first 
screener included 31 titles and the second included 62, 
with both agreeing on 19 of those selections (see online 
supplementary material 1). The overall agreement was 
94%. The second screener agreed with 61% (19/31) of 
the titles selected with the first screener and selected 
an additional 4.7% (43/909) of the titles. The PABAK 
was 0.88. After double-screening the abstracts of the 74 
titles selected by either reviewer, 5 were selected for full-
text review. Of the five papers screened in full, two were 
included. Extrapolating to the total number of titles iden-
tified (n=18 285), it was estimated that had all the identi-
fied titles been screened in this way, then no studies would 
have been missed (see online supplementary material 2).
Titles identified from citation tracking
Twenty per cent (n=145) of the total number of titles 
identified from citation tracking (n=724) were double-
screened. Twelve and 18 titles were selected by the first 
and the second screeners, respectively, with both agreeing 
on 11 of those selections. The overall agreement was 
94%. The second screener agreed with 91% (11/12) of 
the titles selected with the first screener and selected an 
additional 4.8% (7/145) of the titles (PABAK=0.88). On 
screening the abstracts of the eight titles screeners disa-
greed on, only one was selected for full-text review. This 
study was later excluded as it did not involve a compar-
ison group. This suggests that none of the additional titles 
included by second reviewer alone would have made it to 
the included studies.
An update search using the same search strategy for 
articles published between March 2014 and August 2016 
was also undertaken (see figure 3). This identified an 
additional 623 citations after removing the duplicates. 
The 623 titles were independently screened by PA and 
BF. Abstracts of all titles considered potentially relevant 
by either screener were then screened. A total of 97 
abstracts were independently screened by both reviewers 
(PA and BF). Of the nine screened in full, two did not 
meet one or more of the inclusion criteria and one 
was not available in full text. One paper reported data 
from an intervention already included. A total of 5 addi-
tional papers were identified, giving a total of 39 studies 
included in the review (Figure 3).
description of included studies
The main characteristics of the 39 included studies are 
summarised in online supplementary material 3. The 
studies addressed patient delay in a variety of clinical 
contexts: 16 in acute myocardial infarction, 15 in stroke, 
5 in ACS, 2 in cancer and 1 in chest pain. The studies were 
published between 1973 and 2016 and varied geograph-
ically, with 14 studies from the USA or Canada, 6 from 
Germany, 4 each from the UK and Australia, 2 from 
Ireland, 2 each from Sweden and Switzerland, 1 each 
from Norway, Italy, Japan and China, and 1 from multiple 
countries. The studies were heterogeneous in design: 
7 were RCTs10 30–34 with individuals or communities as 
unit of randomisation, 335–37 controlled before and after 
studies, 23 uncontrolled before and after studies, 338–41 
interrupted time series (ITS), 1 case–control study,42 and 
243 44 post-test-only studies.
The study population in the majority of studies (n=24) 
consisted of individuals with a suspected diagnosis, that 
is, presenting with symptoms suggestive of a relevant 
life-threatening condition; 15 studies included only 
those with a confirmed diagnosis. For patient delay 
time, the 7 RCTs reported on a total of 30 888 partic-
ipants, while 32 studies with non-randomised designs 
reported on a total of 169 650 participants. Across all 
studies that reported this information, the average mean 
age of participants was 65.6 years (SD=5.08, range=56–
77), and an average of 42.5% of the participants were 
female (range 16%–100%, SD=14.6). In all studies, the 
data were collected from hospital/outpatients settings, 
with information obtained mainly from patient medical 
records or relevant clinical registries. In all studies with 
before and after designs, prehospital/patient delay time 
was recorded in different people before and after the 
intervention.
All studies evaluated interventions aimed at reducing 
patient delay, that is, the time from onset of symptoms 
to patients seeking medical help. However, the studies 
varied in terms of how this delay was measured. Twen-
ty-four studies assessed prehospital delay, that is, the time 
from symptom onset to arrival at hospital/emergency 
department/coronary care unit; five36 43 45–47 assessed 
patient delay, that is, the time from symptom onset to the 
first medical contact; and five assessed both.44 48–51 Five 
studies did not explicitly report how the delay time was 
measured.41 42 52–54
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Table 8 BCTs and additional techniques used in effective and ineffective studies in ACS (n=5)
BCT 
number BCT label Frequency
Effective ACS
studies in which
this BCT is
present, n (out 
of 3)
Ineffective
ACS studies in
which this BCT is
present, n (out 
of 2)
1.1 Goal-setting (behaviour) 1 1 0
1.2 Problem-solving 6 2 1
1.4 Action planning 27 3 1
3.1 Social support (unspecified) 2 1 0
3.2 Social support (practical) 3 1 1
4.1 Instruction on how to perform the behaviour 4 1 0
4.2 Information about antecedents 1 0 1
5.1 Information about health consequences 16 2 1
5.2 Salience of consequences 4 0 1
6.1 Demonstration of the behaviour 3 0 0
7.1 Prompts and cues 5 1 1
8.1 Behavioural practice/rehearsal 3 1 1
8.2 Behaviour substitution 1 1 0
9.1 Credible source 5 1 0
11.2 Reduce negative emotions 1 0 0
12.5 Adding objects to the environment 3 0 0
13.1 Identification of self as a role model 1 0 0
13.2 Framing/reframing 1 0 1
15.1 Verbal persuasion about capability 1 0 0
Additional techniques 
AT1 Provision of factual information (eg, on signs and symptoms of disease) 36 3 1
AT2 Instruction on behaviour (what to do) 33 3 0
AT3 Instruction on intermediate behaviour 1 0 0
AT4 Information about health consequences of intermediate behaviour 1 0 0
AT5 Reflecting on past experiences 1 1 0
ACS, acute coronary syndrome; BCTs, behaviour change techniques.
Methodological quality
Overall, the methodological quality of included studies 
was mixed (tables 2 and 3). Seven studies were rated as 
strong for protection against allocation bias due to their 
RCT design; most of the remaining were moderately 
rated due to quasi-experimental designs (controlled or 
uncontrolled before and after studies, and ITS). Of the 
seven RCTs, two10 34 were judged to be strong, three15 31 33 
were judged moderate and two30 32 as weak. Of the three 
controlled before and after studies, one35 study was rated 
strong on selection bias and data collection methods, with 
the remainder rated as moderate/weak. All three55–57 
were assessed as moderate on blinding, with two assessed 
as weak on confounders.
Of the 29 remaining non-randomised studies (23 
uncontrolled before and after, 3 ITS, 2 post-test only and 
1 case–control), 738 39 47 49 52–54 58 studies were rated strong 
on selection bias, that is, included samples judged as likely 
to be representative of the target population; majority of 
the remainder rated as moderate or weak (20 moderate; 
2 weak). All were rated weak on data collection methods. 
None received a strong rating on blinding; 25 were rated 
moderate and 5 as weak.
In describing intervention integrity, the percentage 
of participants receiving the allocated intervention was 
reported in 630 34 42 44 46 55 of the 40 studies.
Intervention characteristics
Table 4 summarises the characteristics of interventions 
evaluated in included studies. There was considerable 
variation in the descriptions of interventions between 
studies. Although all interventions were directed at 
patients, 14 studies also included a professional educa-
tion component. Eleven studies reported a theoretical 
basis or underlying framework to their interventions, 
including social marketing principles,44 53–56 58 Leventhal’s 
self-regulatory model,10 15 Safer’s model of patient delay,32 
social cognitive theory and principles of motivational 
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interviewing,34 and a combination of self-regulatory 
model, social cognitive theory, diffusion theory and social 
marketing and community organisation principles.31
Intervention target and setting
Interventions in 30 studies were population-level 
education campaigns aimed at the general public, 
710 15 30 33 34 36 43 were individual-level interventions aimed 
at high-risk individuals, and 231 32 involved both elements. 
All public education campaigns were delivered in the 
community setting (including mass media, GP prac-
tices and pharmacy). Three33 36 43 of the individual-level 
interventions were delivered in the community setting 
and four10 15 30 34 in the hospital setting. Of the interven-
tions involving both individual-level and population-level 
components, one32 was delivered in community setting 
and the other31 in both community and hospital settings.
Intervention mode of delivery, materials, providers and intensity
All public education interventions were mass media 
campaigns often using multiple channels to deliver the 
key intervention message. Nineteen used electronic 
media (television and radio); 23 used print media (news-
papers, magazines, press releases, handbooks, pamphlets, 
leaflets, books); 4 used digital media (eg, mobile phones, 
internet, blogs, emails); 7 used outdoor media (eg, bill-
board, posters); and 13 used face-to-face events on a 
group basis (eg, public meetings, road shows, informa-
tive sessions). The two31 32 interventions with both popu-
lation-level and individual-level elements used electronic 
media and direct mailing; one31 also used face-to-face 
meetings on an individual and group bases. The most 
commonly used materials in these campaigns involved 
television and radio ads/features and posters/flyers/leaf-
lets in public places. The duration of the public educa-
tion campaigns varied considerably, ranging from 1 week 
to 48 months (M=14.5 months, SD=14.1); 15 population 
interventions lasted up to 12 months and 8 lasted between 
13 and 48 months. The duration was not reported in nine 
studies.41 45 49 50 53 56 58–60 Interventions in four studies were 
implemented in two or more phases/waves.38–40 51 55
Three33 36 43 of the individual-level interventions were 
delivered remotely using direct mail (eg, letters/leaf-
lets posted to participants’ homes); four10 15 30 34 were 
delivered face-to-face, one of which also used a directly 
mailed letter and a phone call as reminder and support10; 
and one was delivered in a group format.34 The face-to-
face interventions used a variety of materials including 
action/advisory plans (n=1), stickers (n=2), professional 
scripts (n=2) and educational video (n=2). Three10 15 30 
of four face-to-face interventions were provided, once 
only, by nurses, physicians and the researcher, and lasted 
an average of 28 min (range 5–40 min, SD=20). The 
fourth face-to-face intervention34 was provided in a group 
format, twice, by physicians and health educators, for an 
unspecified duration. Letters were mailed either by physi-
cians, nurses or the research team over an average dura-
tion of 5 months (range 1.5–12 months, SD=5.6).
Intervention tailoring, modifications and fidelity
Most of the interventions were not personally tailored; 
only one of the public education campaigns56 was tailored 
to women aged 40–60 years, two tailored the language of 
the intervention to a specific ethnic/cultural group,34 40 
and two of the one-to-one interventions15 61 were tailored 
to patients’ past experiences and life situation. None of 
the studies described any modifications to the interven-
tions during the course of the study. Six studies, four of 
public education campaigns31 51 55 57 and two of individual 
intervention,10 15 reported assessing fidelity of the inter-
vention. Fidelity of mass media campaigns was assessed 
in terms of the likely reach and impact of the campaign, 
for example, by obtaining measures of intervention 
exposure, viewer ratings and random sample surveys of 
knowledge, attitudes and beliefs. Of the two individual 
intervention trials, only Mooney et al10 reported opti-
mising fidelity through delivery of standardised training 
to providers and monthly reviews of intervention delivery 
and data collection procedures. Dracup et al15 reported 
assessing fidelity by measuring knowledge, attitudes 
and beliefs about ACS in both groups at baseline and 
follow-up.
Behaviour change techniques
A total of 19 BCTs from BCTT V.1 and 5 additional tech-
niques were identified across all 39 intervention descrip-
tions. An average of 2 BCTs (SD=2.3, range 0–10) and 2 
additional techniques per intervention (SD=0.69, range 
0–4) were coded. The most frequently presented BCTs 
were action planning (n=27), information about health 
consequences (n=16), problem-solving (n=6), credible 
source (n=5) and prompts/cues (n=5), and the most 
frequently used additional techniques were provision of 
information on signs and symptoms (n=36) and instruc-
tion on what to do (n=32) (table 5).
Reported intervention effectiveness
Just over half (n=20)10 33 36–38 41 44 48 49 51 52 54 55 57 59 60 62–65 
the studies reported a statistically significant reduction in 
delay following intervention, 2 of which were RCTs,10 33 
while the remaining 191 15 30–32 34 35 39 40 42 43 45–47 50 53 56 58 66 67 
did not, including 5 RCTs.15 30–32 34
Associations between reported intervention effectiveness and 
various study features
BCTs and effectiveness
A visual inspection of the distribution of effective and 
ineffective studies on individual BCTs suggests no clear 
pattern of association between the presence of indi-
vidual BCTs and reported intervention effectiveness. The 
majority of the BCTs were equally likely to be present 
in studies reporting a positive effect on patient delay as 
those reporting no effect (see table 5 and figures 4 and 
5). There was no relationship between the number of 
BCTs present and intervention effectiveness (point-bise-
rial r=−0.086, p=0.602, n=39).
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Intervention and study characteristics, methodological quality and 
effectiveness
Visual inspection of the distribution of studies reporting 
significant and non-significant effects of intervention on 
various study and intervention features (table 4) suggests 
absence of a clear pattern of association between reported 
intervention effectiveness and the examined study/inter-
vention characteristics. Similarly table 6 suggests absence 
of a clear pattern of association between reported inter-
vention effectiveness and methodological quality.
Findings specific to studies measuring patient delay
Ten studies36 43 45–51 68 assessed patient delay, that is, the 
time from symptom onset to first medical contact distinct 
from other aspects of prehospital delay (eg, transporta-
tion time).
Of the ten studies which measured patient delay, 
none were RCTs, one36 was a controlled before and after 
study, seven45–51 were uncontrolled before and after, 
and two43 68 single-group post-test design. Eight45–51 68 
evaluated mass media interventions and two direct mail 
educational interventions.36 43 The most commonly used 
techniques were techniques additional to BCTT V.1: all 
(10/10) studies which measured patient delay included 
AT1 Provision of factual information (eg, on signs and symp-
toms) and almost all (9/10) included AT2 Instruction on 
behaviour (what to do). The results are presented in table 7, 
and it can be seen that there is no clear pattern of associ-
ation between the presence of a particular technique and 
a reduction in patient delay. However, three36 49 51 of the 
four studies,36 47 49 51 which included two or more BCTs in 
addition to the commonly used AT1 and AT2, reported a 
significant reduction in patient delay.
Findings specific to ACs studies
Of the five studies that evaluated an intervention to reduce 
patient delay in ACS, two10 15 were RCTs and two56 63 were 
uncontrolled before and after studies, and one was a 
post-test-only study.44 One of each design10 44 63 reported a 
significant reduction in patient delay following interven-
tion. The two RCTs10 15 evaluated an individual-level inter-
vention delivered face-to-face in a clinical setting. The two 
before and after studies56 63 and one post-test-only study44 
evaluated a population-level mass media campaign aimed 
at reducing patient delay for symptoms of ACS. The most 
commonly used BCTs and additional techniques were 
action planning (n=4) and provision of information on 
signs and symptoms of disease (n=4), respectively. The 
results are summarised in table 8, and visual inspection 
suggests no pattern of association between the presence 
of a technique and reported effectiveness.
dIsCussIOn
This comprehensive and systematic review of the existing 
literature in relation to reducing patient delay with serious 
symptoms has found that only around half of the studied 
interventions report any success in reducing prehospital 
delay. This proportion is similar across study designs, 
mode of delivery, populations and clinical contexts. This 
demonstrates there is still much scope to improve the 
effectiveness of interventions to reduce delay. Despite 
examining a number of components that might explain 
the variation in effectiveness, we were unable to differen-
tiate the studies reporting success from those that did not. 
This is true even if only the subset of studies conducted 
in a cardiac population are examined, and therefore the 
conclusions reflect a limitation of the available literature 
in this area and are not related to the scope of the review. 
When we considered only studies that measured patient 
delay distinct from other aspects of prehospital delay 
(ie, those best suited to answering our question), there 
is some evidence to suggest that additional use of BCTs 
might be helpful, but further robust enquiry is required 
to confirm this finding.
We have identified and described the behaviour 
change components of interventions to reduce patient 
delay. Action planning, information about health conse-
quences and problem-solving were the most frequently 
used BCTs. However, techniques not currently classified 
as BCTs in BCTT V.119 were identified more commonly 
than the most common BCTs: information on signs and 
symptoms and instruction on what to do. This suggests 
there is scope to increase the use of BCTT V.1 techniques 
in interventions to reduce delay.
Unfortunately, missing and highly skewed data 
prevented us from being able to conduct the desired 
meta-analyses to explore whether particular techniques 
are associated with effective interventions. We also 
encountered some difficulties in applying BCTT V.1 to 
BCTs delivered by mass media to public health campaigns. 
Possible adjustments to BCTT V.1 have been suggested 
via the online feedback portal: https://www. ucl. ac. uk/ 
behaviour- change- techniques/ BCTTv1Feedback.
In common with previous attempts to systematically 
review behaviour change interventions, the quality of 
intervention reporting was mixed.69 70 It is difficult to 
identify BCTs in poorly described interventions, although 
still possible to achieve reliability between coders.71 Tech-
niques were described in reports using terms similar to 
the labels used in the taxonomy but with descriptions 
that differed from those provided by BCTT V.1. For 
example, ‘action planning’ occurred in interventions, 
but the accounts mostly described linking symptoms with 
specific actions and plans being given to patients rather 
than actively involving them in planning. This reinforces 
the urgent need for the ‘common language’ and unam-
biguous definitions provided by BCTT V.119 to ensure 
when interventions or components of interventions are 
described or reviewed that it is possible to compare like 
with like.
Guidelines have been produced in efforts to improve 
reporting standards,26 and as journals begin to require 
authors to adhere to these (eg, http://www. journals. else-
vier. com/ social- science- and- medicine/ policies) interven-
tion descriptions are likely to improve. Thus, in time, it 
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will likely become easier to extract information about 
BCTs in reviews and for the purposes of secondary anal-
ysis. In the meantime, sole reliance on systematic reviews 
of evidence produced prior to such guidance to identify 
potentially useful BCTs in interventions is fraught with 
difficulty and may be best supplemented with other trans-
parent, systematic methods (eg, we undertook an expert 
consensus study in parallel).
limitations
This review is limited as it only assesses published mate-
rials. Despite our best efforts, described in the search 
strategy section (above) to obtain additional information 
from authors and the ‘grey literature’, we did not identify 
data suitable for inclusion in the review that had not been 
published. There is thus the potential that publication 
bias has resulted in studies with negative findings being 
less likely to be identified.72
Some methodological problems were encountered 
during the course of this review, which we outline briefly 
to inform future reviews in this area. Difficulties were 
encountered judging the methodological quality of some 
studies due to the nature of study designs—for example, 
before and after assessments carried out in different 
people; in RCTs, assessments of intervention consistency 
and fidelity are difficult in public health campaigns; and 
judgements about contamination or cointervention are 
next to impossible, particularly in studies of public health 
campaigns. Future study designers should be cognisant of 
these issues and authors must ensure complete reporting. 
There may be scope for methodological advances to be 
made in relation to assessing public health campaign 
data for meta-analysis.
We were unable to locate guidance on how to deter-
mine the EPHPP global quality score, which is weighted 
for the number of high/poor quality ratings, when one or 
more dimensions are not applicable. Although we were 
able to find examples of approaches other authors had 
taken,73 detailed guidance would help ensure a consis-
tent approach and facilitate robust comparisons between 
studies.
COnClusIOn
This review has found that only half of the interventions 
to reduce prehospital delay with time-critical symptoms 
report significantly reduced delay times. Some limited 
evidence suggests that additional use of BCTs might be 
helpful in reducing patient delay in particular. The BCTs 
most commonly identified within interventions are action 
planning, information about health consequences and prob-
lem-solving, plus the additional techniques identified as 
information on signs and symptoms and instruction on what to 
do. However we were unable to establish if any particular 
BCT differentiates effective interventions from non-effec-
tive interventions. Much remains to be done to under-
stand how to effectively influence patient decision time. 
The task will be expedited if researchers use consistent 
measures of decision time, provide comprehensive inter-
vention descriptions and use agreed definitions of BCTs.
Author affiliations
1School of Health & Social Care, Edinburgh Napier University, Edinburgh, UK
2School of Health Sciences, University of Stirling, Stirling, UK
3NHS Tayside School of Nursing & Midwifery, University of Dundee, Dundee, UK
4Faculty of Kinesiology, University of New Brunswick, New Brunswick, Canada
5Health Sciences Research Unit, University of Aberdeen, Aberdeen, UK
6Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
Acknowledgements Sheena Moffat, Librarian at Edinburgh Napier University for 
valuable assistance with the search.
Funding This work was supported by the Chief Scientist Office, Scotland (grant 
number CZH/4/1025).
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
data sharing statement No additional data are available.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4.0
RefeRences
 1. Ho MT, Eisenberg MS, Litwin PE, et al. Delay between onset of chest 
pain and seeking medical care: the effect of public education. Ann 
Emerg Med 1989;18:727–31.
 2. NICE. Chest pain of recent onset: assessment and diagnosis, 2010.
 3. Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the 
management of acute coronary syndromes in patients presenting 
without persistent ST-segment elevation: task force for the 
management of acute coronary syndromes in patients presenting 
without persistent ST-segment elevation of the European Society of 
Cardiology (ESC). 
 4. O'Connor RE, Brady W, Brooks SC, et al. Part 10: acute coronary 
syndromes: 2010 American heart association guidelines for 
cardiopulmonary resuscitation and emergency cardiovascular care. 
Circulation 2010;122(18):S787–17.
 5. Scarborough P. Trends in coronary heart disease 1961–2011, 2011.
 6. World Health OrganizationMendis S, Puska P, Norrving B, eds. 
Global atl ason cardiovascular diseaseprevention and control, 2008.
 7. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary 
heart disease mortality in England and Wales between 1981 and 
2000. Circulation 2004;109:1101–7.
 8. Schiele F, Hochadel M, Tubaro M, et al. Reperfusion strategy in 
Europe: temporal trends in performance measures for reperfusion 
therapy in ST-elevation myocardial infarction. Eur Heart J 
2010;31:2614–24.
 9. Saczynski JS, Yarzebski J, Lessard D, et al. Trends in prehospital 
delay in patients with acute myocardial infarction (from the Worcester 
Heart Attack Study). Am J Cardiol 2008;102:1589–94.
 10. Mooney M, McKee G, Fealy G, et al. A randomized controlled trial 
to reduce prehospital delay time in patients with acute coronary 
syndrome (ACS). J Emerg Med 2014;46:495–506.
 11. GISSI. Epidemiology of avoidable delay in the care of patients with 
acute myocardial infarction in Italy. A GISSI-generated study. GISSI--
avoidable delay study group. Arch Intern Med 1995;155:1481–8.
 12. Safer MA, Tharps QJ, Jackson TC, et al. Determinants of three 
stages of delay in seeking care at a medical clinic. Med Care 
1979;17:11–29.
 13. Task Force on the management of ST-segment elevation acute 
myocardial infarction of the European Society of Cardiology (ESC), 
Steg PG, James SK, et al. ESC Guidelines for the management of 
acute myocardial infarction in patients presenting with ST-segment 
elevation. Eur Heart J 2012;33:2569–619.
 o
n
 1 M
arch 2019 by guest. Protected by copyright.
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2018-000975 on 27 February 2019. Downloaded from
 
Open Heart
18 Farquharson B, et al. Open Heart 2019;6:e000975. doi:10.1136/openhrt-2018-000975
 14. Kainth A, Hewitt A, Sowden A, et al. Systematic review of 
interventions to reduce delay in patients with suspected heart attack. 
Emerg Med J 2004;21:506–8.
 15. Dracup K, McKinley S, Riegel B, et al. A randomized clinical trial 
to reduce patient prehospital delay to treatment in acute coronary 
syndrome. Circ Cardiovasc Qual Outcomes 2009;2:524–32.
 16. Webb TL, Joseph J, Yardley L, et al. Using the internet to promote 
health behavior change: a systematic review and meta-analysis 
of the impact of theoretical basis, use of behavior change 
techniques, and mode of delivery on efficacy. J Med Internet Res 
2010;12:e4.
 17. Smith SM, Murchie P, Devereux G, et al. Developing a complex 
intervention to reduce time to presentation with symptoms of lung 
cancer. Br J Gen Pract 2012;62:e605–15.
 18. Smith S, Fielding S, Murchie P, et al. Reducing the time before 
consulting with symptoms of lung cancer: a randomised controlled 
trial in primary care. Br J Gen Pract 2013;63:e47–54.
 19. Michie S, Richardson M, Johnston M, et al. The behavior change 
technique taxonomy (v1) of 93 hierarchically clustered techniques: 
building an international consensus for the reporting of behavior 
change interventions. Ann Behav Med 2013;46:81–95.
 20. Farquharson B, Dombrowski S, Pollock A, et al. Reducing patient 
delay with symptoms of acute coronary syndrome: a research 
protocol for a systematic review of previous interventions to 
investigate which behaviour change techniques are associated with 
effective interventions. Open Heart 2014;1:e000079.
 21. Editors PLM, PLoS Medicine Editors. Best practice in systematic 
reviews: the importance of protocols and registration. PLoS Med 
2011;8:e1001009.
 22. Effective Public Health Practice Project. (1998). Quality assessment 
tool for quantitative studies, 2009. Available from: http://www. ephpp. 
ca/ tools. html
 23. Armstrong R, Waters E, Doyle J. Chapter 21: reviews in health 
promotion and public health. Cochrane handbook for systematic 
reviews of interventions. The Cochrane Collaboration, 2008.
 24. Thomas BH, Ciliska D, Dobbins M, et al. A process for systematically 
reviewing the literature: providing the research evidence for 
public health nursing interventions. Worldviews Evid Based Nurs 
2004;1:176–84.
 25. Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 Statement: 
updated guidelines for reporting parallel group randomised trials. 
BMC Med 2010;8:18.
 26. Hoffmann TC, Glasziou PP, Boutron I, et al. Better reporting of 
interventions: template for intervention description and replication 
(TIDieR) checklist and guide. BMJ 2014;348
 27. Wan X, Wang W, Liu J, et al. Estimating the sample mean and 
standard deviation from the sample size, median, range and/or 
interquartile range. BMC Med Res Methodol 2014;14:135.
 28. Altman DG, Bland JM. Statistics notes: detecting skewness from 
summary information. BMJ 1996;313:1200.
 29. Jackson N. Handbook: systematic reviews of health promotion and 
public health interventions. Victoria: The Cochrane Collaboration, 
Victorian Health Promotion Foundation, 2007.
 30. Blank FS, Smithline HA. Evaluation of an educational video for 
cardiac patients. Clin Nurs Res 2002;11:403–16.
 31. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community 
intervention on patient delay and emergency medical service use in 
acute coronary heart disease: the Rapid Early Action for Coronary 
Treatment (REACT) Trial. JAMA 2000;284:60–7.
 32. Meischke H, Dulberg EM, Schaeffer SS, et al. 'Call fast, Call 911': 
a direct mail campaign to reduce patient delay in acute myocardial 
infarction. Am J Public Health 1997;87:1705–9.
 33. Müller-Nordhorn J, Wegscheider K, Nolte CH. Population-
based intervention to reduce prehospital delays in patients with 
cerebrovascular events. Arch Intern Med 2009;169:1484–90.
 34. Boden-Albala B, Stillman J, Roberts ET, et al. Comparison of acute 
stroke preparedness strategies to decrease emergency department 
arrival time in a multiethnic cohort: the stroke warning information 
and faster treatment study. Stroke 2015;46:1806–12.
 35. Morgenstern LB, Staub L, Chan W, et al. Improving delivery of acute 
stroke therapy: the TLL temple foundation stroke project. Stroke 
2002;33:160–6.
 36. Rowley JM, Hill JD, Hampton JR, et al. Early reporting of myocardial 
infarction: impact of an experiment in patient education. Br Med J 
1982;284:1741–6.
 37. Sun XG, Zhang N, Wang T, et al. Public and professional education 
on urgent therapy for acute ischemic stroke: a community-based 
intervention in changsha. Neurol Sci 2013;34:2131–5.
 38. Hodgson C, Lindsay P, Rubini F. Can mass media influence 
emergency department visits for stroke? Stroke 2007;38:2115–22.
 39. Mellon L. An evaluation of the first national media campaign to 
increase stroke awareness in Ireland. Cerebrovascular Diseases, 
2011: 292.
 40. Mellon L, Hickey A, Doyle F, et al. Can a media campaign change 
health service use in a population with stroke symptoms? 
Examination of the first Irish stroke awareness campaign. Emerg 
Med J 2014;31:536–40.
 41. Rustige J, Schiele R, Schneider J, et al. Intravenous thrombolysis 
in acute myocardial infarct: optimization of the therapeutic strategy 
by informing the patients and physicians. Anasthesiol Intensivmed 
Notfallmed Schmerzther 1992;27:205–8.
 42. Tummala SR, Farshid A. Patients' understanding of their heart attack 
and the impact of exposure to a media campaign on pre-hospital 
time. Heart Lung Circ 2015;24:4–10.
 43. Månsson J, Marklund B, Bengtsson C, et al. Evaluation of an 
educational programme for the early detection of cancer. Patient 
Educ Couns 1999;37:231–42.
 44. Bray JE, Stub D, Ngu P, et al. Mass media campaigns’ influence on 
prehospital behavior for acute coronary syndromes: an evaluation 
of the Australian heart foundation's warning signs campaign. J Am 
Heart Assoc 2015;4.
 45. Bett JH, Tonkin AM, Thompson PL, et al. Failure of current public 
educational campaigns to impact on the initial response of patients 
with possible heart attack. Intern Med J 2005;35:279–82.
 46. Bett N, Aroney G, Thompson P. Impact of a national educational 
campaign to reduce patient delay in possible heart attack. Aust N Z 
J Med 1993;23:157–61.
 47. Waters WE, Wheeller MJ, Fraser JD, et al. Evaluation of a health 
education campaign to reduce the delay in women presenting with 
breast symptoms. Community Med 1983;5:104–8.
 48. Gaspoz JM, Unger PF, Urban P, et al. Impact of a public campaign 
on pre-hospital delay in patients reporting chest pain. Heart 
1996;76:150–5.
 49. Luiz T, Moosmann A, Koch C, et al. Optimized logistics in the 
prehospital management of acute stroke. Anasthesiol Intensivmed 
Notfallmed Schmerzther 2001;36:735–41.
 50. Thomassen L, Waje-Andreassen U, Maintz C. Thrombolytic therapy 
in acute cerebral infarction--a time study when organizing a new 
therapeutic option. Tidsskr Nor Laegeforen 1999;119:2978–81.
 51. Wolters FJ, Paul NL, Li L, et al. Sustained impact of UK FAST-test 
public education on response to stroke: a population-based time-
series study. Int J Stroke 2015;10:1108–14.
 52. Maeso-Madronero JL. HEUH 'Recognition of myocardial infarction 
and correct acting' - A project aiming at reducing the prehospital 
delay Ttime in acute myocardial infarction German. Herz Kreislauf 
2000;32:257–62.
 53. Rau R, Otten K, Genz J. Evaluation of the public-health intervention 
"healthy lower rhine.against stroke" by means of clinic data in the 
district of Wesel, Germany. Comparative study with clinic data 
samples in 2003 and in 2005. Med Klin 2008;103:20–8.
 54. Breuer H, K E. The Gorlitz myocardial infarction project: an 
information campaign to reduce the prehospital time of acute 
myocardial infarctions in Eastern Saxonia [German]. Herz Kreislauf 
1999;31:443–7.
 55. Herlitz J, Blohm M, Hartford M, et al. Follow-up of a 1-year media 
campaign on delay times and ambulance use in suspected acute 
myocardial infarction. Eur Heart J 1992;13:171–7.
 56. Diercks DB, Owen KP, Kontos MC, et al. Gender differences in 
time to presentation for myocardial infarction before and after a 
national women's cardiovascular awareness campaign: a temporal 
analysis from the Can Rapid Risk Stratification of Unstable Angina 
Patients Suppress ADverse Outcomes with Early Implementation 
(CRUSADE) and the National Cardiovascular Data Registry Acute 
Coronary Treatment and Intervention Outcomes Network-Get 
with the Guidelines (NCDR ACTION Registry-GWTG). Am Heart J 
2010;160:80–7.
 57. Mitic WR, Perkins J. The effect of a media campaign on heart attack 
delay and decision times. Can J Public Health 1984;75:414–8.
 58. Wright RS, Kopecky SL, Timm M, et al. Impact of community-based 
education on health care evaluation in patients with acute chest pain 
syndromes: the Wabasha Heart Attack Team (WHAT) project. Fam 
Pract 2001;18:537–9.
 59. Alberts MJ, Perry A, Dawson DV, et al. Effects of public and 
professional education on reducing the delay in presentation and 
referral of stroke patients. Stroke 1992;23:352–6.
 60. Barsan WG, Brott TG, Broderick JP, et al. Urgent therapy for 
acute stroke. Effects of a stroke trial on untreated patients. Stroke 
1994;25:2132–7.
 61. Mooney M, McKee G, Fealy G, et al. A review of interventions aimed 
at reducing pre-hospital delay time in acute coronary syndrome: 
what has worked and why? Eur J Cardiovasc Nurs 2012;11:445–53.
 o
n
 1 M
arch 2019 by guest. Protected by copyright.
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2018-000975 on 27 February 2019. Downloaded from
 
19Farquharson B, et al. Open Heart 2019;6:e000975. doi:10.1136/openhrt-2018-000975
Cardiac risk factors and prevention
 62. Black LA, Brown DD. Public information and heart attack. Report of 
an educational program. Ohio State Med J 1973;69:369–74.
 63. Naegeli B, Radovanovic D, Rickli H, et al. Impact of a nationwide 
public campaign on delays and outcome in Swiss patients 
with acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 
2011;18:297–304.
 64. Camerlingo M, D'Asero S, Perego L, et al. How to improve access 
to appropriate therapy and outcome of the acute ischemic stroke: a 
24-month survey of a specific pre-hospital planning in Northern Italy. 
Neurol Sci 2014;35:1359–63.
 65. Nishijima H, Kon T, Ueno T, et al. Effect of educational television 
commercial on pre-hospital delay in patients with ischemic stroke. 
Neurol Sci 2016;37:105–9.
 66. Addo J, Ayis S, Leon J, et al. Delay in presentation after an acute 
stroke in a multiethnic population in South london: the South london 
stroke register. J Am Heart Assoc 2012;1:e001685.
 67. Moses HW, Engelking N, Taylor GJ, et al. Effect of a two-year 
public education campaign on reducing response time of patients 
with symptoms of acute myocardial infarction. Am J Cardiol 
1991;68:249–51.
 68. Bray JE, Stub D, Ngu P, et al. Mass media Campaigns’ influence on 
prehospital behavior for acute coronary syndromes: an evaluation 
of the Australian heart foundation's warning signs campaign. J Am 
Heart Assoc 2015;4.
 69. Dombrowski S, Sniehotta F, Avenell A. Current issues and future 
directions in psychology and health : towards a cumulative 
science of behaviour change: do current conduct and reporting of 
behavioural interventions fall short of best practice? Psychology & 
Health 2007;22:869–74.
 70. Dombrowski SU, Sniehotta FF, Avenell A, et al. Identifying active 
ingredients in complex behavioural interventions for obese adults 
with obesity-related co-morbidities or additional risk factors 
for co-morbidities: a systematic review. Health Psychol Rev 
2012;6:7–32.
 71. Abraham C, Wood CE, Johnston M, et al. Reliability of identification 
of behavior change techniques in intervention descriptions. Ann 
Behav Med 2015;49:885–900.
 72. Dwan K, Altman DG, Arnaiz JA, et al. Systematic review of the 
empirical evidence of study publication bias and outcome reporting 
bias. PLoS One 2008;3:e3081.
 73. Chillón P, Evenson KR, Vaughn A, et al. A systematic review of 
interventions for promoting active transportation to school. Int J 
Behav Nutr Phys Act 2011;8:10.
 o
n
 1 M
arch 2019 by guest. Protected by copyright.
http://openheart.bmj.com/
O
pen Heart: first published as 10.1136/openhrt-2018-000975 on 27 February 2019. Downloaded from
 
